Eris Lifesciences Limited, Ahmedabad vs. NFAC, Delhi (Present Jurisdiction- the Dy. CIT, Circle-2(1)(1)), Ahmedabad
In the result, for assessment year 2022-23, the appeal of the Department is partly allowed for statistical purposes
ITA 915/AHD/2025[2022-23]Status: DisposedITAT Ahmedabad09 Dec 2025AY 2022-23
Bench: Dr. Brr Kumar & Shri Siddhartha Nautiyal
For Appellant: Respondent by: Shri R P Rastogi, CIT-DR & Shri Abhijit, Sr. DRFor Respondent: Shri R P Rastogi, CIT-DR & Shri Abhijit, Sr. DR
Section 14ASection 36(1)(va)Section 37(1)Section 43BSection 80
…rofessional services. The Tribunal specifically held that the principle of tax-neutrality has no application where expenditure itself is prohibited by law. 26. Likewise, in Stemade Biotech (P.) Ltd. v. DCIT [2022] 138 taxmann.com 368 (Mumbai – Trib.) / [2022] 195 ITD 346 (Mumbai ITA Nos. 847to850/Ahd/2025 & 912to915/Ahd/2025 DCIT vs. Eris Lifesciences Ltd. Eris Lifesciences Ltd. vs. DCIT Asst. Years–2018-19 & 2020-21 to 2022-23 - 18– – Trib.), it has been held that referral fees paid by companies to doctors for referring clients are squarely prohibited under Regulation 6.8.1(d) of the MCI Regulations and theref…